In the analysis for RFS, differential expression of ZNF611, ZNF304, RIPK1, DUSP8, TNFRSF21 and HRAS genes was associated with outcome for breast cancer patients who received radiotherapy. This evidence concerns the gene ZNF611 and breast carcinoma.